Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Dare Bioscience Inc. (DARE)

0.9951   -0.015 (-1.48%) 07-07 15:28
Open: 1 Pre. Close: 1.01
High: 1.01 Low: 0.99
Volume: 129,711 Market Cap: 27M
Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's reproductive health products in the United States. The company intends to develop therapies in the areas of contraception, vaginal health, sexual health, and fertility. Its product portfolio includes Ovaprene, a non-hormonal monthly contraceptive vaginal ring; Sildenafil Cream, a novel cream formulation of sildenafil to treat female sexual arousal disorder utilizing the active ingredient in Viagra; DARE-BV1, a hydrogel formulation of clindamycin phosphate 2% to treat bacterial vaginosis via a single application; and DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for hormone replacement therapy. The company has license agreement with ADVA-Tec, Inc.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.011 - 1.018 1.018 - 1.024
Low: 0.967 - 0.974 0.974 - 0.98
Close: 1 - 1.012 1.012 - 1.021

Technical analysis

as of: 2020-07-07 3:03:31 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.20     One year: 1.28
Support: Support1: 0.91    Support2: 0.76
Resistance: Resistance1: 1.03    Resistance2: 1.10
Pivot: 1.02
Moving Average: MA(5):     MA(20): 1.02
MA(100): 1.02     MA(250): 0.94
MACD: MACD(12,26): -0.01     Signal(9): -0.01
Stochastic oscillator: %K(14,3): 45.61     %D(3): 45.56
RSI: RSI(14): 43.55
52-week: High: 2.22  Low: 0.69  Change(%): 19.6
Average Vol(K): 3-Month: 40626  10-Days: 25803

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
DARE has closed above bottom band by 15.5%. Bollinger Bands are 59% narrower than normal. The narrow width of the bands suggests low volatility as compared to DARE's normal range. The bands have been in this narrow range for 47 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 07 Jul 2020
Vaginitis Therapeutics Market Competitive Landscape Analysis with Forecast by 2026 – Bausch Health, DARÉ BIOSCIENCE, INC, Hennepin Life Sciences, LLC - Daily Research Advisor

Thu, 02 Jul 2020
Dare Bioscience, Inc. (DARE) Technical And Fundamental Data On The Rise - Invest Million

Wed, 24 Jun 2020
Dare Bioscience (DARE) Announces Publication of Peer-Reviewed Journal Article Supporting Use of Postcoital Test Study as Predictor of Contraceptive Effectiveness by Biology of Reproduction -

Thu, 18 Jun 2020
Is Dare Bioscience, Inc. (DARE) a good SWING-TRADE Candidate? - The News Heater

Wed, 17 Jun 2020
Daré Bioscience Announces Initiation of Pivotal Phase 3 Study of DARE-BV1 in Patients with Bacterial Vaginosis - GlobeNewswire

Wed, 17 Jun 2020
BRIEF-Daré Bioscience Announces Initiation Of Pivotal Phase 3 Study Of DARE-BV1 - Reuters

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 27
Shares Float (M) 24
% Held by Insiders 12.65
% Held by Institutions 3.72
Shares Short (K) 172
Shares Short P. Month (K) 240

Stock Financials

EPS -0.870
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.130
Profit Margin
Operating Margin
Return on Assets (ttm) -127.3
Return on Equity (ttm) -442.2
Qtrly Rev. Growth
Gross Profit (p.s.) -0.020
Sales Per Share
EBITDA (p.s.) -0.581
Qtrly Earnings Growth
Operating Cash Flow (M) -17
Levered Free Cash Flow (M) -9

Stock Valuations

PE Ratio -1.14
PEG Ratio
Price to Book value 7.62
Price to Sales
Price to Cash Flow -1.59

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.